Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limitedverified

BXPHF

Price:

$0.0764

Market Cap:

$236.24M

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that ...[Read more]

Industry

Biotechnology

IPO Date

2019-09-09

Stock Exchange

OTC

Ticker

BXPHF

The ROE as of December 2025 (TTM) for Botanix Pharmaceuticals Limited (BXPHF) is -99.43%

According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -99.43%. This represents a change of 227.48% compared to the average of -30.36% of the last 4 quarters.

Botanix Pharmaceuticals Limited (BXPHF) Historical ROE (quarterly & annually)

How has BXPHF ROE performed in the past?

The mean historical ROE of Botanix Pharmaceuticals Limited over the last ten years is -338.60%. The current -99.43% ROE has changed -70.64% with respect to the historical average. Over the past ten years (40 quarters), BXPHF's ROE was at its highest in in the December 2015 quarter at 101.83%. The ROE was at its lowest in in the June 2019 quarter at -2090.00%.

Quarterly (TTM)
Annual

Average

-338.60%

Median

-69.20%

Minimum

-2769.60%

Maximum

-12.76%

Botanix Pharmaceuticals Limited (BXPHF) ROE by Quarter and Year

Discovering the peaks and valleys of Botanix Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.00%

Maximum Annual ROE = -12.76%

Minimum Annual Increase = -97.44%

Minimum Annual ROE = -2769.60%

Quarterly (TTM)
Annual
YearROEChange
2025-106.27%733.09%
2024-12.76%-68.02%
2023-39.88%-75.31%
2022-161.57%908.01%
2021-16.03%-77.36%
2020-70.78%-97.44%
2019-2769.60%4.00%
2018-67.62%-22.97%
2017-87.79%63.50%
2016-53.70%-34.98%

Botanix Pharmaceuticals Limited (BXPHF) Average ROE

How has BXPHF ROE performed in the past?

The current ROE of Botanix Pharmaceuticals Limited (BXPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-52.97%

5-year avg

-67.30%

10-year avg

-338.60%

Botanix Pharmaceuticals Limited (BXPHF) ROE vs. Peers

How is BXPHF’s ROE compared to its peers?

Botanix Pharmaceuticals Limited’s ROE is greater than Innate Pharma S.A. (-658.91%), greater than NDT Pharmaceuticals Inc. (-20.34%), greater than Molecular Partners AG (-50.31%), less than Scancell Holdings plc (126.94%), greater than Brii Biosciences Limited (-14.61%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), greater than Hofseth BioCare ASA (-279.05%), greater than Ascend Wellness Holdings, Inc. (-225.92%), less than Kintor Pharmaceutical Limited (0%), greater than NervGen Pharma Corp. (-879.68%),

Build a custom stock screener for Botanix Pharmaceuticals Limited (BXPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Botanix Pharmaceuticals Limited (BXPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Botanix Pharmaceuticals Limited's ROE?

How is the ROE calculated for Botanix Pharmaceuticals Limited (BXPHF)?

What is the highest ROE for Botanix Pharmaceuticals Limited (BXPHF)?

What is the 3-year average ROE for Botanix Pharmaceuticals Limited (BXPHF)?

What is the 5-year average ROE for Botanix Pharmaceuticals Limited (BXPHF)?

How does the current ROE for Botanix Pharmaceuticals Limited (BXPHF) compare to its historical average?